Introduction
The nitric oxide (NO) role in acute pancreatitis (AP) pathogenesis remains controversial 1 with some studies suggesting that it potentiates the oxidative stress and pancreatic parenchyma injury, 2, 3 while others report that it reduces the pancreatic dysfunction by increasing pancreatic blood flow in response to NO releasing by endothelial cells. [4] [5] [6] [7] NO is synthesized from L-arginine by action of a single enzyme, oxide nitric synthase (NOS). NO action can be blocked by methylene blue (MB), a GMPc inhibitor. 8, 9 MB blocks GMP-c increase, the ultimate effector pathway of NO production with vasodilatation action. MB also may inhibit the NO synthesis.
MB clinical use has been reported in sepses, renal and hepatic transplantation, anaphylactic shock and shock associated to extracorporal circulation.
In the present study, MB was employed to evaluated the hemodynamic and biochemical effects in a severe AP model in pigs. The animals were anaesthetized with Midazolan (15 mg i.m. Cristália Chemical Products Ltda., Itapira, S.P., Brazil) and Tiletamine/Zolazepam (10 mg.kg-1 body weight -Telazol®, Fort Dodge, WI, USA) followed by a continuous i.v. infusion of Sulfentanil in the dose of 100 mg.h-1 (Fastfan®, Cristália Chemical Products Ltda., Itapira, S.P., Brazil) and Propofol (10 mg.kg-1.h-1 Propovan®, Cristália Chemical Products Ltda., Itapira, S.P., Brazil) using a syringe pump (Syringe Infusion Pump, Harvard Apparatus, South Natick, Me, U.S.A.). Muscle relaxation was obtained with acid pancuronic (6 mg.h-1 Pancuron®, Cristália Chemical Products Ltda., Itapira, S.P., Brazil). The animals received 3 ml of sodium chloride 0,9%.kg-1 body weight.h-1 i.v. to compensate insensitive losses. During the procedure the animals were kept in mechanic ventilation (TakaokaModel6000) with FiO2 of 40% and a intratracheal pressure of 8 mmHg. Venous access was obtained throughout the right jugular vein and a Swan-Ganz catheter (CCOmbo CCO/ SvO2 744HF75 Edwards Lifesciences, Irvine, CA, U.S.A) was introduced. Arterial access was obtained throughout the right femoral artery and a polyethylene catheter was introduced. The abdominal wall was opened by a midline incision extending about 15cm from the xiphoid region. The duodenum as well the main pancreatic duct were identified. The main pancreatic duct was carefully isolated, opened and canalled using a catheter as described previously.
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The pancreatic catheter was exteriorized throughout the abdominal incision that was closed in a continuously fashion.
Data Collection. After surgical and anaesthetic procedures had been accomplishment including tracheostomy, venous and arterial access, hemodynamic monitoring, blood samples collection, main pancreatic duct cannulation, the animals were observed by a period of 45 minutes for hemodynamic stability. After this stability period, hemodynamic parameters were collected and registered continuously for 180 min using a MP System 100 (BioPacSystem, Incorporation, Santa Barbara, CA, U.S.A.). Arterial and venous blood samples were collected to biochemical analyses every 60 min from the beginning of the experiment (instant zero). 1 body weight during a 1 minute period was performed as described also were. 10, 11 MB infusion. MB (Merck Diagnostica, Darmstadt, Germany) infusion was carried through an initial dose of 2mg.kg-1 body weight diluted in 20 ml of 0,9% sodium chloride solution followed by a maintenance dose of 2 mg.kg-1 body weight.h-1 was done by a continuous intravenous infusion throughout the experiment.
Nitrate Dosage. Serum nitrate was indirectly measured by a Sievers NOAnalizer 280i using a NO/ozone chemioluminiscence technique. 12 Malondialdehyde Dosage. MDA dosage was done using a Lipid Peroxidation Assay (Calbiochem San Diego, CA, U.S.A) as described previously. 
Pancreas Biopsy and Morphologic Study.
At the end of data collection the previous laparotomy was extended from the xiphoid to the suprapubic region and the animals were sacrificed by exsanguination. The pancreas was identified, isolated and removed in all its extension. The pancreas was immediately fixed in a 10% formol solution, after which time the slides were prepared from paraffin blocks and stained with hematoxylin-eosin stain. Biopsy samples from all 30 animals were then examined blindly in order to eliminate observer bias. The slides were screened under light microscope for swelling, inflammatory infiltration, necrosis and hemorrhage.
Statistical Analysis
The results were expressed in arithmetic mean and standard deviation (sd). Serum amylase, glucose, creatinin and hematocrit were analyzed in 60 minutes intervals from time zero. Collected data were stored in a computer and plot in spread sheets of the Excel program (Microsoft, Seatle, WA, the U.S.A), and statistically analyzed using a Minitab 
Results
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Serum glucose, creatinin and hematocrit results are showed in Table 3 . Serum glucose levels decreased (p<0.05) in MB group at 120 and 180 min; in MB+AP group at 60, 120 and 180 min; in AP and AP+MB groups at 60 and 180 min. No difference (p>0.05) were seen among groups.
Creatinin serum levels increased (p<0.05) in all AP groups AP at 180 min, moreover in AP+MB group that increased (p<0.05) at 120 min. Creatinin serum levels were elevated (p<0.05) in MB+AP group when compared to AP group at 180 min.
Hematocrit increased (p<0.05) in all AP groups. At the end of the experiment, there were a mean increase of 32, 26, and 20 % in AP, MB+AP and AP+MB groups, respectively.
Pancreatic morphological study from CTL and MB groups showed normal gland. However, pancreas from all AP groups presented with bright dark reddish surface with black spots, swelled and jelly consistence. Microscopy study in CTL and MB groups was unremarkable but it revealed necrosis and hemorrhage in all AP groups. None leukocytes infiltration was seen.
Discussion
MB has been used as a therapeutic drug for more than 110 years 14 mainly for methemoglobinemia treatment, cyanate antidote and fistula localization. 15 In AP group, venous nitrate levels increased over time and arterial nitrate levels were higher when compared with group CTL. This increase was associated with hypotension, CO and PCP decrease and hemoconcentration. In severe AP, inducible nitric oxide synthase (iNOS) overproduces NO. Excessive NO production cause pathological vasodilatation with capillary permeability increase and third space fluid loss 16 and tissue injury by NO derived free-radicals overproduction. AL MUFTI et al. (1998) demonstrated an increase in iNOS activity associated to systemic NO increase and arterial hypotension in AP experimental models. 17, 18 Thus, inhibition of iNOS may have a potential benefic effect in a variety of pathophysiologic alterations in AP.
The findings of MBP, CVP, CO and CI reduction in AP group associated to HR, SVR and PVR increase with hemoconcentration confirm the method reproducibility regarding precocious hypovolemic shock manifestations in this AP experimental model. 19 CO and CI reduction during AP induction is primarily related to hypovolemia and due to preload reduction. 20 Experimental studies had demonstrated that MBP decrease correspond to 26 to 45% circulating volume decrease 21, 22 In this study it was 32% in AP group.
Our objective was to evaluate initial AP treatment with MB without volemic replacement. When compared AP groups there was a delay in CO and CI reduction in MB+AP group although there were no difference at the end of the experiment. In AP group it initiated at 70 minutes and only at 140 minutes in MB+AP group. However, MB given 90 minutes after AP induction, did not revert the hemodynamic changes. When there is volemic replacement, CO and CI do not decrease in severe AP initial phase and hemoconcentration precedes hemodynamic alteration 23 Hemoconcentration was present 10 minutes before CO and CI decrease in AP group. Furthermore, in MB+AP group occurred hemoconcentration at least 50 minutes before CO and CI decrease. We observed that MB (dose of 2mg.kg MB inhibition on NO vasodilatation and prostaglandins action may explain PVR increase in septic shock and inflammatory conditions where both action are increased 25 differently from normal physiological conditions as seen in MB group. DO 2 diminished in AP groups although MB immediately before AP induction delayed DO 2 decrease, most probably related to CO decrease. O 2 EI increase observed in AP groups reflects AP hypovolemic condition and it suggests a compensation attempt due to DO 2 decrease and VO 2 increase. 26 However, AP patients that had volemic correction with crystalloid solutions present DO 2 and VO 2 increase suggesting that AP increases metabolic demand. 26 Serum nitrate levels increase was not observed when MB was used either before or after AP induction. An unexpected reduction of arterial and venous serum nitrate levels were observed suggesting inhibition of NO effect independent of GMPc inhibition 27 . However, this effect seems partial because MB did not decrease serum nitrate levels in the MB+AP or AP+MB groups. This mechanism can be due to the production of superoxide, a NO inactivator. Oxidatio of the reduced form of MB induces the generation of this free radical 27, 28 , justifying the findings of MDA increases associated to MB infusion".
Free radicals (FR) generation seems to be involved in AP experimental models correlated to ischemia, alcohol and biliary etiology. 29, 30 However, MDA serum levels did not increased in AP group. Different experimental models of AP seem to present different degrees and mechanisms of FR formation, with lesser impact in taurocholate-induced AP. 30 Adversely, MB promoted increase of MDA serum levels with a significant impact when it was associated with AP. There are evidence that L-NAME induces the RL production 31, 32 . MARCZIN et al. 33 had demonstrated that, in physiological conditions, MB inactives NO with consequent increase in superoxide concentration and lipoperoxidation. 34 Therefore, it seems that MDA serum increase in group MB corresponds probably to NO inactivation with consequent NO physiological actions blockage. MDA levels increase, associated with the use of MB during AP, seems not to be associated to initial NO production by iNOS. The NO release, in great amounts, demand necessary time since the initial stimulation to its final production that involves cellular enzymatic mechanisms. The NO increase occurred 180 min after AP induction.
NO may be a cytotoxic mediator during taurocholate-induced AP. 3 In fact, NO cytotoxicity is attributed to its reaction with ion superoxide forming peroxynitrite. 35, 36 Although peroxynitrite production precedes iNOS expression, there was no MDA increase in AP group.
Initial studies in sepsis had shown that NO overproduction is responsible by hypotension and that iNOS blockage improves it without improving mortality. [37] [38] [39] The reason is due to no selective iNOS inhibitors, that NO blocking interferes with perfusion regulation, capillary permeability and leukocytes/platelets interactions. A possible explanation for these findings may be that NO blockage by MB improved systemic hemodynamic parameters during AP, although in the cellular level it promoted a poor tissue perfusion due to its vasoconstrictor action. Moreover, MB increases platelets activity in hypovolemic and hemoconcentration conditions propitiating lipoperoxidation and tissue perfusion aggravation. Serum amylase levels increase, MB+AP and AP+MB groups, may correspond to suppression of NO beneficial effect in pancreatic microcirculation. NO is a mediator that increases pancreatic blood flow in response to physiological stimulation of CCK and secretin. 40 NO may confer protection against AP development, probably due to pancreatic microcirculation improvement and leukocytes adhesion reduction. [41] [42] [43] Serum creatinin increase in AP groups is in accordance with LEVY et al. 44 that demonstrated acute renal insufficiency consequence to hypovolemia in taurocholateinduced AP model. Serum creatinin worsening in AP+MB group confirms MB vasoconstrictor effect on renal circulation thus aggravating a vasoconstriction due to hypovolemia.
Hypoglycemia occurred in all groups except in group CTL. Hypoglycemia in AP groups may be explained by cells beta destruction and insulin release during taurocholate-induction AP. On the other hand, MB group also presented hypoglycemia over time probably due to a blockage of an insulin inhibitory secretion mechanism NO dependent. 45, 46 There was no improvement in necrohemorrhagic findings with MB treatment.
In this taurocholate-induced AP model we concluded that MB treatment delayed hemodynamic shock and decreases serum nitrate levels but increases serum MDA levels. In our experiment, no volemic replacement was done and it may have been a mitigated factor to a poor tissue perfusion and impairment microcirculation. Further investigations are needed to elucidate MB treatment role during AP treatment. 
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Comments:
Current literature data indicates that methylene blue may reverse or ameliorate hemodynamic alterations caused by the systemic inflammatory syndrome through blockage of nitric oxide activity. Nitric oxide is a vasodilator and regulates the exocrine and endocrine (insulin) pancreatic secretion and the microvascular blood flow. The use of NO in acute experimental pancreatitis shows controversial results. Some studies (Werner et al., 1997; Molero et al., 1995) suggest a protective effect probably due to increased blood flow in the pancreatic micro circulation. Waindebach et al. (1995) did not observe any effect of NO in acute pancreatitis, but others (Dabrowiski et al.,1994; Iomis et al., 1995) had evidence of an injurious effect, thought to be due to oxidative stress, vasodilatation and tissue hypoperfusion. In this study, Meirelles et al. proposed the study of hemodynamic profiles and lipid peroxidation in pigs with acute pancreatitis induced by taurocholate enterokinase, and submitted to treatment with methylene blue, as a NO inhibitor, before and after pancreatitis induction. The dye was able to reduce serum nitrate levels, but lipid peroxidation was increased as shown by serum levels of malon dialdehyde. The results in the study warrant the conclusion that the use of methylene blue before induction of severe acute experimental pancreatitis offered a transitory protection to hemodynamic shock. However, there was a deleterious effect on lipid peroxidation and the claim that there is an improvement in circulatory shock by the use of methylene blue should be avoided.
